0 10 Activation Activation NNP 11 13 of of IN 14 19 human human JJ 20 36 immunodeficiency immunodeficiency NN 37 42 virus virus NN 43 47 type type NN 48 49 1 1 CD 50 60 expression expression NN 61 63 by by IN 64 75 Gardnerella gardnerella FW 76 85 vaginalis vaginalis FW 85 86 . . . 88 97 Bacterial bacterial JJ 98 107 vaginosis vaginosis NN 108 109 ( ( ( 109 111 BV BV NNP 111 112 ) ) ) 113 115 is be VBZ 116 126 associated associate VBN 127 131 with with IN 132 134 an an DT 135 144 increased increase VBN 145 149 rate rate NN 150 152 of of IN 153 159 sexual sexual JJ 160 172 transmission transmission NN 173 175 of of IN 176 181 human human JJ 182 198 immunodeficiency immunodeficiency NN 199 204 virus virus NN 205 206 ( ( ( 206 209 HIV HIV NNP 209 210 ) ) ) 211 215 type type NN 216 217 1 1 CD 217 218 , , , 219 222 and and CC 223 234 Gardnerella gardnerella FW 235 244 vaginalis vaginalis FW 245 247 is be VBZ 248 258 frequently frequently RB 259 267 isolated isolate VBN 268 272 from from IN 273 276 the the DT 277 284 genital genital JJ 285 291 tracts tract NNS 292 294 of of IN 295 300 women woman NNS 301 305 with with IN 306 308 BV BV NNP 308 309 . . . 310 312 G. g. FW 313 322 vaginalis vaginalis FW 323 330 lysates lysate NNS 331 335 were be VBD 336 341 found find VBN 342 344 to to TO 345 358 significantly significantly RB 359 368 stimulate stimulate VB 369 372 HIV HIV NNP 373 383 expression expression NN 384 386 in in IN 387 397 monocytoid monocytoid JJ 398 403 cells cell NNS 403 404 . . . 405 416 Stimulation stimulation NN 417 420 was be VBD 421 434 significantly significantly RB 435 441 higher high JJR 442 446 when when WRB 447 454 lysates lysate NNS 455 459 were be VBD 460 466 heated heat VBN 467 469 at at IN 470 473 100 100 CD 474 481 degrees degree NNS 482 483 C c JJ 484 487 for for IN 488 489 5 5 CD 490 493 min min NN 494 497 but but CC 498 501 was be VBD 502 509 reduced reduce VBN 510 512 by by IN 513 522 treatment treatment NN 523 527 with with IN 528 536 lysozyme lysozyme NN 537 539 or or CC 540 548 protease protease NN 548 549 . . . 550 552 G. g. FW 553 562 vaginalis vaginalis FW 563 570 lysates lysate NNS 571 575 also also RB 576 585 activated activate VBD 586 589 HIV HIV NNP 590 600 expression expression NN 601 603 in in IN 604 611 certain certain JJ 612 613 T t NN 614 618 cell cell NN 619 624 lines line NNS 624 625 . . . 626 628 G. g. FW 629 638 vaginalis vaginalis FW 639 646 lysates lysate NNS 647 656 activated activate VBD 657 660 HIV HIV NNP 661 674 long-terminal long-terminal JJ 675 681 repeat repeat NN 682 695 transcription transcription NN 696 698 in in IN 699 711 HIV-infected hiv-infected JJ 712 717 cells cell NNS 718 721 and and CC 722 731 increased increase VBD 732 741 NF-kappaB NF-kappaB NNP 742 749 binding binding NN 750 758 activity activity NN 758 759 , , , 760 770 indicating indicate VBG 771 773 an an DT 774 780 effect effect NN 781 783 by by IN 784 786 G. g. FW 787 796 vaginalis vaginalis FW 797 799 on on IN 800 803 HIV HIV NNP 804 817 transcription transcription NN 817 818 . . . 819 822 The the DT 823 833 activation activation NN 834 836 of of IN 837 840 HIV HIV NNP 841 851 production production NN 852 854 by by IN 855 857 G. g. FW 858 867 vaginalis vaginalis FW 868 876 suggests suggest VBZ 877 881 that that IN 882 889 genital genital JJ 890 895 tract tract NN 896 905 infection infection NN 906 910 with with IN 911 913 G. g. FW 914 923 vaginalis vaginalis FW 924 933 increases increase VBZ 934 937 the the DT 938 942 risk risk NN 943 945 of of IN 946 949 HIV HIV NNP 950 962 transmission transmission NN 963 965 by by IN 966 976 increasing increase VBG 977 980 HIV HIV NNP 981 991 expression expression NN 992 994 in in IN 995 998 the the DT 999 1006 genital genital JJ 1007 1012 tract tract NN 1012 1013 . . . 1014 1018 This this DT 1019 1022 may may MD 1023 1030 explain explain VB 1030 1031 , , , 1032 1034 at at IN 1035 1040 least least JJS 1041 1043 in in IN 1044 1048 part part NN 1048 1049 , , , 1050 1053 the the DT 1054 1063 increased increase VBN 1064 1068 rate rate NN 1069 1071 of of IN 1072 1075 HIV HIV NNP 1076 1088 transmission transmission NN 1089 1091 in in IN 1092 1097 women woman NNS 1098 1102 with with IN 1103 1105 BV BV NNP 1105 1106 . . .